These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3525058)

  • 1. Preprogrammed intravenous insulin infusion in diabetic humans: metabolic consequences of altering meal size.
    Levy-Marchal C; Perlman K; Zinman B; Albisser AM
    Diabetes Care; 1986; 9(3):283-90. PubMed ID: 3525058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antecedent caloric intake and glucose excursion following a subsequent meal in Type 1 diabetes.
    Mehra R; Raman R; Bayless ML; Sivitz WI
    J Diabetes; 2009 Dec; 1(4):273-7. PubMed ID: 20700478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of plasma glucose, serum insulin, and C-peptide responses to three isocaloric breakfasts in non-insulin-dependent diabetic subjects.
    Colagiuri S; Miller JJ; Holliday JL; Phelan E
    Diabetes Care; 1986; 9(3):250-4. PubMed ID: 3525055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic response to fasting exercise in adolescent insulin-dependent diabetic subjects treated with continuous subcutaneous insulin infusion and intensive conventional therapy.
    Schiffrin A; Parikh S; Marliss EB; Desrosiers MM
    Diabetes Care; 1984; 7(3):255-60. PubMed ID: 6376018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary carbohydrate, a Big Mac, and insulin requirements in type I diabetes.
    Vlachokosta FV; Piper CM; Gleason R; Kinzel L; Kahn CR
    Diabetes Care; 1988 Apr; 11(4):330-6. PubMed ID: 3042309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dietary fiber on postprandial glycemic profiles in diabetic patients submitted to continuous programmed insulin infusion.
    Chenon D; Phaka M; Monnier LH; Colette C; Orsetti A; Mirouze J
    Am J Clin Nutr; 1984 Jul; 40(1):58-65. PubMed ID: 6331149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diet liberalization and metabolic control in type I diabetic outpatients treated by continuous subcutaneous insulin infusion.
    Chantelau E; Sonnenberg GE; Stanitzek-Schmidt I; Best F; Altenähr H; Berger M
    Diabetes Care; 1982; 5(6):612-6. PubMed ID: 6927731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
    Bode BW; Johnson JA; Hyveled L; Tamer SC; Demissie M
    Diabetes Technol Ther; 2017 Jan; 19(1):25-33. PubMed ID: 28055230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of temporal distribution of calories on diurnal patterns of glucose levels and insulin secretion in NIDDM.
    Beebe CA; Van Cauter E; Shapiro ET; Tillil H; Lyons R; Rubenstein AH; Polonsky KS
    Diabetes Care; 1990 Jul; 13(7):748-55. PubMed ID: 2201497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic effects of continuous subcutaneous insulin infusion: evidence that a rise and fall of portal vein insulin concentration with each major meal facilitates post-absorptive glycemic control.
    Rodger NW; Behme MT; Dupre J; Chamberlain MJ
    Clin Invest Med; 1988 Jun; 11(3):167-86. PubMed ID: 3042215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic/metabolic responses to identical meal tolerance tests at breakfast, lunch and dinner in Japanese patients with type 2 diabetes mellitus treated with a dipeptidyl peptidase-4 inhibitor and the effects of adding a mitiglinide/voglibose fixed-dose combination.
    Ono Y; Kamoshima H; Nakamura A; Nomoto H
    Expert Opin Pharmacother; 2014 Sep; 15(13):1785-95. PubMed ID: 25046055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Continuous subcutaneous insulin infusion brings about normal blood sugar in type I diabetes mellitus despite relaxing of diet instructions].
    Sonnenberg GE; Chantelau E; Altenähr H; Berger M; Berchtold P
    Schweiz Med Wochenschr; 1982 Jan; 112(3):83-5. PubMed ID: 7036337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic control with closed-loop intraperitoneal insulin in type I diabetes.
    LeBlanc H; Chauvet D; Lombrail P; Robert JJ
    Diabetes Care; 1986; 9(2):124-8. PubMed ID: 3516606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of digestible carbohydrates on glucose control in insulin-dependent diabetic patients.
    Perrotti N; Santoro D; Genovese S; Giacco A; Rivellese A; Riccardi G
    Diabetes Care; 1984; 7(4):354-9. PubMed ID: 6088192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma immunoreactive somatostatin response to arginine after glycemic control with continuous subcutaneous insulin infusion in type I diabetics.
    Kobayashi T; Sawano S; Itoh T; Kosaka K
    Diabetes Care; 1987; 10(3):286-92. PubMed ID: 2885161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percentage of carbohydrate and glycemic response to breakfast, lunch, and dinner in women with gestational diabetes.
    Peterson CM; Jovanovic-Peterson L
    Diabetes; 1991 Dec; 40 Suppl 2():172-4. PubMed ID: 1748252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient treatment of juvenile-onset diabetes with a preprogrammed portable subcutaneous insulin infusion system.
    Tamborlane WV; Sherwin RS; Genel M; Felig P
    Am J Med; 1980 Feb; 68(2):190-6. PubMed ID: 6986766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine-metabolic function in remission-phase IDDM during administration of cyclosporine.
    Dupre J; Jenner MR; Mahon JL; Purdon C; Rodger NW; Stiller CR
    Diabetes; 1991 May; 40(5):598-604. PubMed ID: 2022304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of plasma glucose and insulin responses to mixed meals of high-, intermediate-, and low-glycemic potential.
    Hollenbeck CB; Coulston AM; Reaven GM
    Diabetes Care; 1988 Apr; 11(4):323-9. PubMed ID: 3042308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.